INTRODUCTION
Erythropoiesis in mammals is regulated primarily by the glycoprotein hormone, erythropoietin (ESF)1 (1) . Since adenyl cyclase-linked mechanisms regulate differentiation, growth, and function in a number of tissues, such mechanisms may also influence erythropoiesis. Evidence that selected cyclic nucleotides may stimulate mammalian erythropoiesis has been provided by in vitro studies demonstrating that cyclic AMP (cAMP) increases canine hemoglobin synthesis in marrow suspension culture (2) and enhances ESFdependent erythroid colony formation in semisolid media (3) . Since the presence of ESF is essential for colony formation, and since the cells most responsive to cAMP or ESF are physically and functionally dissimilar, it has been proposed that mechanisms linked to cyclic nucleotides may modulate in vitro ESF action (4) . ,8-Adrenergic catecholamines are naturally occurring hormones which influence cellular metabolic events by interacting with specific cell surface receptors which are linked to membrane-bound adenyl cyclase. Thus, when the (8-adrenergic hormone binds to its surface receptor, intracellular cAMP levels rise (5) . The purpose of this study is to characterize the effect of adrenergic agents on in vitro erythroid proliferation. The results demonstrate that /8-adrenergic agonists significantly enhance ESF-dependent canine erythroid colony growth and that the receptor has /32-subspecificity. It The various compounds to be tested were added to appropriate culture dishes containing the bovine citrated plasma. The cell-containing mixture was added, and the contents of the plate were rapidly mixed and allowed to clot. The cultures were then incubated at 37°C in a high humidity, 5% C02-95% air, tissue culture incubator (Napco Industries, Inc. Portland, Oreg.). After a 48-h incubation, the clots were fixed with 5% glutaraldehyde in phosphate-buffered saline, and the colonies were counted by using an inverted tissue culture microscope (7) . To confirm the identity ofhemoglobincontaining cells and thereby verify the counting results, some of the clots were removed from the dishes and stained with benzidine (8) .
To L-propranolol and n-propranolol (Ayerst Laboratories, Montreal, Canada); practolol (8, [14] ; Ayerst Laboratories); and butoxamine (82 [15] ; Burroughs-Wellcome Co., Research Triangle Park, N. C.).
Other agents known to participate in the adenyl cyclasecAMP system were also tested, including dibutyryl-cAMP (Sigma Chemical Co.), the phosphodiesterase inhibitor, RO-20-1724 ([16] ; Roche Diagnostics Div., HoffmannLaRoche, Inc., Nutley, N. J.), and the nonspecific adenyl cyclase stimulator, cholera enterotoxin (17, 18) . The cholinergic compound, carbamylcholine (Sigma Chemical Co.), was also examined. All of these agents were dissolved in HBSS with the exception ofRO-20-1724, which was dissolved in ethanol. In control cultures, identical volumes of ethanol (1-10 ulIml) had no effect in colony formation.
Tritiated thymidine [3H]TdR suicide kinetics. The cycle characteristics of colony-forming cells responding to ESF and to isoproterenol were compared by [3H]TdR suicide kinetics as described previously (19, 20) . Control cell suspensions were incubated in HBSS alone, in HBSS containing nonradioactive thymidine, and in HBSS containing both radioactive and unlabeled thymidine.
CeU separation by velocity sedimentation. Physical properties of the colony-forming cell populations responding to ESF orB-agonists were compared by the technique ofvelocity sedimentation at unit gravity (21) . Red cell contamination of the cell suspension was reduced before loading the gradient by taking only the buffy coat from the cell pellets after each HBSS wash, thereby achieving a nucleated: nonnucleated cell ratio of 1:3-4. The cell concentration was then adjusted to 2.7 x 106/ml in HBSS containing 5% fetal calf serum, and the gradient loaded, allowed to settle, and analyzed as described previously (20) .
RESULTS
Canine marrow cells cultured under the conditions described form colonies of hemoglobin-synthesizing cells in response to added ESF. Each colony arises from a single progenitor, the erythroid colonyforming unit, and colony numbers are related linearly to the number of nucleated cells plated (3) and to the logarithm of the concentration of added ESF up to 1.0 IRP U/ml (Fig. 8 ).
When the ,8-adrenergic agonist, isoproterenol (1 nM-1 uM), was added to cultures in combination with suboptimal concentrations ofESF (0.5 IRP U/ml), enhancement of colony numbers was observed. This enhancement was concentration dependent with the maximal effect seen at 0.1 ,uM (Fig. 1) colony growth was eliminated by a 10 nM concentration of the global (8-blocker, propranolol (Fig. 2) , strongly suggesting that the effect of the agonist is due to interaction with a (8-receptor. While propranolol inhibited the growth of isoproterenol-induced colonies, it had no effect, up to 10lM, on the number of ESF-dependent colonies.
To clarify the specificity of the (-adrenergic effect, two types of experiments were carried out. First, the blocking effect of propranolol was tested in cultures containing other stimulators of the adenyl cyclasecAMP mechanism (Fig. 3) . Although propranolol completely blocked the effect of isoproterenol, it failed to inhibit the increased colony numbers induced by dibutyryl cAMP, RO-20-1724, or cholera enterotoxin. Thus, these other agents probably act at cytoplasmic sites or at cell surface locations which are separate from the ,(-receptor. In the second approach to the question of the (3-specificity of the isoproterenol effect, the blocking properties ofthe D-and L-isomers ofpropranolol were compared. Fig. 4 shows that D-propranolol at 0.1 /M had no influence on colony numbers whereas 0.1 nM L-propranolol completely inhibited isoproterenol-induced colonies.
The adrenergic receptor was further characterized by adding to cultures several a-and ,8-adrenergic stimulators having different relative receptor selectivities (Fig. 5) (Fig. 8) . The ,3-agonist continued to enhance colony formation even at optimal concentrations of ESF (above 1.0 IRP U/ml). Aye (22) has shown that a soluble product from adherent cells enhances human erythroid colony growth. In the current study (data not shown) all of the enhancing factors tested remained active in the absence of adherent cells, which had previously been removed by polyester fiber filtration (22) , or in the presence ofbuffy coat-conditioned medium (23) . Thus, the influence of adenyl cyclase-linked mechanisms on erythroid colony growth does not appear to be mediated by adherent cells.
[3H ]TdR suicide kinetics. 
DISCUSSION
The role of adenyl cyclase-linked mechanisms in the regulation of in vitro erythropoiesis has been examined by a number of researchers; however, the results have been either inconclusive or contradictory. Some studies have demonstrated that cAMP stimulates in vitro erythropoiesis as measured by such parameters as heme synthesis or erythroblast numbers (24) (25) (26) (27) although others have not shown such an effect (28, 29) . In fetal rat liver, although stimulation of heme synthesis by ESF has been shown, no effect of ESF on cAMP levels was noted. In this same tissue, however, marked elevations in cAMP levels were induced by epinephrine (30) . It is likely that the variable effects of cAMP noted in these different studies are due to variations in the species chosen as marrow source (2) and the erythropoietic parameter selected for measurement.
Recently, cyclic nucleotides have been shown to stimulate hemoglobin synthesis and enhance erythroid colony formation in cultures employing canine and human marrow cells, effects which are specific for cyclic adenosine nucleotides (2,3). On analysis, however, a number of differences were found between cAMP and ESF in the functional and physical characteristics of the cell populations responsive to the respective agents. First, while cAMP enhanced colony growth, only ESF was capable of initiating erythroid colony formation (3). Second, the adenyl cyclase stimulator, cholera enterotoxin, continued to augment colony formation (3), and cAMP continued to induce hemoglobin synthesis in cell cultures (2) 
